Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 4/2000

01-12-2000 | Original article

Clinical significance of disordered beta-catenin expression pattern in human gastric cancers

Authors: Takehiro Utsunomiya, Yuichiro Doki, Hiroyoshi Takemoto, Hitoshi Shiozaki, Masahiko Yano, Masatoshi Inoue, Takushi Yasuda, Yoshiyuki Fujiwara, Morito Monden

Published in: Gastric Cancer | Issue 4/2000

Login to get access
Metadata
Title
Clinical significance of disordered beta-catenin expression pattern in human gastric cancers
Authors
Takehiro Utsunomiya
Yuichiro Doki
Hiroyoshi Takemoto
Hitoshi Shiozaki
Masahiko Yano
Masatoshi Inoue
Takushi Yasuda
Yoshiyuki Fujiwara
Morito Monden
Publication date
01-12-2000
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 4/2000
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/PL00011717

Other articles of this Issue 4/2000

Gastric Cancer 4/2000 Go to the issue

Original article

Prognostic factors in patients with advanced gastric cancer with macroscopic invasion to adjacent organs treated with radical surgery

Original article

Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer

Original article

Expression of transforming growth factor β (TGF-β) may contribute, in part, to the variations in histogenesis and the prevalence of peritoneal dissemination in human gastric carcinoma

Original article

Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers

Case report

Advanced gastric glandular-endocrine cell carcinoma with 1-year survival after gastrectomy

Original article

Gastric cancer with extragastric lymph node metastasis: multivariate prognostic study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits